Remdesivir for the Treatment of Covid-19 — Preliminary Report. NEJM, May 22nd, 2020

Spread the word

A double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults hospitalized with Covid-19 with evidence of lower respiratory tract involvement. For more information please click here.

Leave a Reply

Your email address will not be published. Required fields are marked *